BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $110
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation EW | 0.00 |
BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:
EW) with a Buy and raises the price target from $100 to $110.
